Treatment of Low-Risk Basal Cell Carcinoma.

Nicole W J Kelleners-Smeets, Klara Mosterd, Patty J Nelemans

The Journal of investigative dermatology 2017 Mar

filter terms:

With the continuously rising incidence and changing populations of patients with basal cell carcinoma, evidence about the different treatment modalities is mandatory. Randomized clinical trials, such as the surgery versus imiquimod for nodular superficial basal cell carcinoma trial, can provide this evidence. Patients can then be informed about all aspects of alternative treatment options so that conscious, shared decisions can be made. Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Citation

Nicole W J Kelleners-Smeets, Klara Mosterd, Patty J Nelemans. Treatment of Low-Risk Basal Cell Carcinoma. The Journal of investigative dermatology. 2017 Mar;137(3):539-540